Insider Transactions in Q3 2019 at Crispr Therapeutics Ag (CRSP)
Insider Transaction List (Q3 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 01
2019
|
Samarth Kulkarni Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
740
-0.45%
|
$34,040
$46.21 P/Share
|
|
Aug 02
2019
|
Tony W Ho Executive VP, Head of R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
14,534
-24.08%
|
$755,768
$52.56 P/Share
|
|
Aug 01
2019
|
Tony W Ho Executive VP, Head of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+38.32%
|
-
|
|
Jul 11
2019
|
Lawrence Otto Klein CBO & COO |
SELL
Open market or private sale
|
Direct |
8,421
-29.63%
|
$421,050
$50.01 P/Share
|
|
Jul 11
2019
|
Lawrence Otto Klein CBO & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,421
+22.86%
|
$42,105
$5.86 P/Share
|
|
Jul 10
2019
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
50,000
-5.57%
|
$2,500,000
$50.0 P/Share
|
|
Jul 10
2019
|
Lawrence Otto Klein CBO & COO |
SELL
Open market or private sale
|
Direct |
11,579
-36.67%
|
$578,950
$50.02 P/Share
|
|
Jul 10
2019
|
Lawrence Otto Klein CBO & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,579
+26.83%
|
$57,895
$5.86 P/Share
|